Drug Profile
MG 56
Alternative Names: Manano; MG56-I; MG56-II; MG56-III; MG56-IV; MG56-V; MG56-VI; MG56-VII; MG56-VIII; Pollen allergen extracts - InmunotekLatest Information Update: 22 Nov 2021
Price :
$50
*
At a glance
- Originator Inmunotek
- Class Allergens; Allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Allergic rhinitis; Allergic rhinoconjunctivitis
Most Recent Events
- 01 Nov 2021 Inmunotek completes Phase-II clinical trials in Allergic rhinitis and Allergic rhinoconjunctivitis (In adolescents, In adults) in Spain (SC and Sublingual) (NCT02654223) (EudraCT2014-005471-88)
- 14 Oct 2021 Phase-II development is ongoing Spain (NCT02654223) (EudraCT2014-005471-88) (Inmunotek pipeline, October 2021)
- 16 Jan 2018 Phase-II development is ongoing Spain (NCT02654223)